Tevard Biosciences is a biotechnology startup that is pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases. Since its founding in 2017, the company has been focused on leveraging this innovative approach to make significant advancements in the fields of biotechnology and health and wellness. Tevard Biosciences has the potential to revolutionize the treatment of genetic diseases, offering a promising solution to addressing a wide spectrum of medical conditions. As the company continues to make strides in its research and development efforts, it presents an intriguing opportunity for venture capital firms looking to invest in cutting-edge biotech innovations. With the potential to make a profound impact on the healthcare industry, Tevard Biosciences is a compelling prospect for investors seeking to support groundbreaking advancements in genetic therapeutics.
Tevard Biosciences
Pioneering tRNA therapeutics to modulate mRNA function and cure a broad range of genetic diseases.
Cambridge, United States
27 employees
Biotechnology, Health and Wellness
General Information
Get notified when Tevard Biosciences moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Tevard Biosciences
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
United States Market
Biotechnology
AI Insight
Bounce Watch AITevard Biosciences is strategically enhancing its industry visibility and validating its deep scientific expertise in RNA medicines through recent high-profile engagements. Key executives are participating in prominent industry discussions, while a co-founder was recently recognized among the 'Giants of Medicine,' underscoring the team's profound scientific contributions. These developments signal a concerted effort to build reputation and attract further interest as the company progresses in its tRNA therapeutics development.
About Tevard Biosciences
Taxonomy: tRNA therapeutics, mRNA modulation, Genetic diseases, Gene therapy, Rare diseases, AAV, Therapeutics, Genetic medicine, Biomedical innovation
No funding data available for Tevard Biosciences yet.
Get notified when Tevard Biosciences raises fundingTevard Biosciences Alternatives & Competitors
Innovative research solutions for rare diseases
Pioneering breakthroughs in genetic disorders and liver diseases using RNA interference technology.
EveryONE Medicines delivers individualized precision therapeutics customized to the unique genetic m...
FAQ About Tevard Biosciences
Don't just browse. Track.
Signal Tracker monitors Tevard Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.